Microbial transformation of curcumin by Rhizopus chinensis

Biocatalysis and Biotransformation

Volumn 28, Issue 5-6, 2010, Pages 380-386

  Zhang, Xing ^a,b   Ye, Min ^a   Li, Rui ^a   Yin, Jun ^b   Guo, De An ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Biotransformation; Curcumin; Fungi; Glucosylation; Rhizopus chinensis

Indexed keywords

ABSIDIA COERULEA; ANTI-TUMORS; BIOTRANSFORMATION; BIOTRANSFORMATION PRODUCT; BIOTRANSFORMATION REACTIONS; CLINICAL USE; CUNNINGHAMELLA ELEGANS; CURCUMIN; FILAMENTOUS FUNGI; FUNGAL STRAINS; GLUCOSYLATION; MICROBIAL TRANSFORMATION; NATURAL PRODUCTS; POTENT ANTIOXIDANTS; RHIZOPUS CHINENSIS; STRUCTURAL MODIFICATIONS; WATER SOLUBILITIES;

BIOCHEMISTRY; CARBOHYDRATES; DRUG PRODUCTS; FUNGI;

BIOCONVERSION;

CURCUMIN; GLUCOSIDE;

ABSIDIA; ALTERNARIA ALTERNATA; ARTICLE; ASPERGILLUS NIGER; BACTERIUM TRANSFORMATION; BIOTRANSFORMATION; CHAETOMIUM; CUNNINGHAMELLA ELEGANS; DRUG BIOAVAILABILITY; DRUG SYNTHESIS; GIBBERELLA FUJIKUROI; GLYCOSYLATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PENICILLIUM; RHIZOPUS; SACCHAROMYCES CEREVISIAE;

ABSIDIA COERULEA; CUNNINGHAMELLA ELEGANS; FUNGI; RHIZOPUS MICROSPORUS VAR. CHINENSIS;

EID: 78650615821     PISSN: 10242422     EISSN: 10292446     Source Type: Journal    
DOI: 10.3109/10242422.2010.532870     Document Type: Article

References (14)

1. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. 2007. Bioavailability of curcumin: problems and promises. Mol Pharm 4:807-818.
2. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Hari-kumar KB, Sung B, Tharakan ST, Misra K, Priyadarsini I, Rajasekharan KN, Aggarwal BB. 2008. Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochem Pharmacol 76:1590-1611.
3. Dai JG, Qu RJ, Zou JH, Chen XG. 2008. Structural diversifi ca-tion of taxanes by whole-cell biotransformation. Tetrahedron 64:8102-8116.
4. Hergenhahn M, Bertram B, Wiessler M, Sorg BL. 2002. Saccha-ride- containing curcumin derivatives with improved water solu-bility for pharmaceuticals. PCT Int Appl WO 2002002582.
5. 2 production. Cancer Res 61:1058-1064.
6. Itokawa H, Morita H, Midorikawa I, Aiyama R, Morita M. 1985. Diarylheptanoids from the rhizome of Alpinia offi cinarum Hance. Chem Pharm Bull 33:4489-4493.
7. Itokawa H, Shi Q, Akiyama T, Morris-Natschke SL, Lee KH. 2008. Recent advances in the investigation of curcuminoids. Chin Med 3:11-23.
8. Jiang HL, Somogyi A, Jacobsen NE, Timmermann BN, Gang DR. 2006a. Analysis of curcuminoids by positive and negative elec-trospray ionization and tandem mass spectrometry. Rapid Commun Mass Spectrom 20:1001-1012.
9. Jiang HL, Timmermann BN, Gang DR. 2006b. Use of liquid chromatography-electrospray ionization tandem mass spec-trometry to identify diarylheptanoids in turmeric (Curcuma longa L.) rhizome. J Chromatogr A 1111:21-31.
10. Johnson JJ, Mukhtar H. 2007. Curcumin for chemoprevention of colon cancer. Cancer Lett 255:170-181.
11. Kaminaga Y, Nagatsu A, Akiyama T, Sugimoto N, Yamazaki T, Maitani T, Mizukami H. 2003. Production of unnatural gluco-sides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthusroseus. FEBS Lett 555:311-316.
12. Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y 1993. Studies on crude drugs effective on visceral larva migrans. XVI. Nematocidal activity of turmeric: synergistic action of curcu-minoids. Chem Pharm Bull 41:1640-1643.
13. Mohri K, Watanabe Y, Yoshida Y, Satoh M, Isobe K, Sugimoto N, Tsuda Y 2003. Synthesis of glycosylcurcuminoids. Chem Pharm Bull 51:1268-1272.
14. Shishodia S, Chaturvedi MM, Aggarwal BB. 2007. Role of cur-cumin in cancer therapy. Curr Probl Cancer 31:243-305.